Delivery Order SPE2DB20D3103-SPE2DB25FM2P8

Award Date 1/8/25
Potential Completion Date 1/9/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $3,004.88 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of EPHEDRINE 50 MG/10 ML VIAL 10ML, a critical medical commodity. Amerisourcebergen holds a $999,999,999 IDC with the DLA that serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $1,104.50 firm-fixed-price delivery order is for the supply of 4562851036 - EPHEDRINE 50 MG/10 ML VIAL 10ML. The contract has a period of performance through November 20, 2023 and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $10,074.55, is for the delivery of 4,564,060,192 milliliters of Ephedrine Sulfate 50 mg/mL to support military treatment programs and facilities. This delivery order is part of a broader indefinite delivery...
This federal contract award is for the delivery of Ephedrine Sulfate 50 mg/ml vials to the Medical Supply Chain division of the Defense Logistics Agency (DLA), a defense agency. The $2,735.02 Firm Fixed Price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 14, 2024 with a completion date of November 15, 2024. This delivery order is issued under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is a Delivery Order worth $1,032.01 for the supply of 4565110751 - Ephedrine 50 mg/10 ml vial, 10 ml. The contract has a completion date of July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999.00 with the DLA Troop Support Medical through December 31,...
This federal contract award, valued at $1,931.09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December 31, 2025. The contract is for the supply of Ephedrine Sulfate 50 mg/mL intravenous medication, a critical pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,676.62 firm fixed-price delivery order is for the supply of 4560894880 units of EPHEDRINE 50 MG/10 ML VIAL 10ML. The contract has a completion date of May 11, 2023. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies,...
This federal contract award, valued at $2,120.39, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The delivery order is for the supply of 4564559773 - Ephedrine Sulfate 50 mg/ml vials, with a completion date of May 10, 2024. AmerisourceBergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through...
This federal contract award is for the delivery of Ephedrine Sulfate 50 mg/mL Injection to the Defense Logistics Agency (DLA). The contract, valued at $1,418.51, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The order is for the supply of Ephedrine Sulfate 50 mg/ml injection vials, with a potential value of $2,394.97 and a completion date of March 6, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through...
  • SPE2DB20D3103
    Indefinite Delivery Contract
  • SPE2DB20D3103-SPE2DB25FM2P8
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,124.25, is for the delivery of 4566875232 EPHEDRINE 50 MG/10 ML VIAL 10ML. The award is a Delivery Order placed under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 4/9/25, 9:52 AM